Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 21INDUSTRY 9NIH 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Endocrine 1

Conditions

Prostatic Neoplasms 2Multiple Endocrine Neoplasia Type 1 1

Interventions

Cyclophosphamide 388Specimen Handling 377Magnetic Resonance Spectroscopy 328Radiotherapy 306Biopsy 273Cisplatin 258Carboplatin 255Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 183Bevacizumab 181Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 141Taxes 127Docetaxel 122Chemotherapy, Adjuvant 114Oxaliplatin 113fludarabine phosphate 111Methotrexate 108Rituximab 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Dutasteride × Clear all
NCT00398281 2014-01-10

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Completed
450 enrolled
Genitourinary

Prostatic Neoplasms

NCT01193855 2013-08-26

Dutasteride in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT00493987 2010-05-13

5aR

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Completed
184 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡